Marianne Byrne

Aug 27, 2024 | onlinelibrary.wiley.com | Marianne Byrne |Hannah Ryan |Gregory J. Dore |Jason Grebely

DAA direct-acting antiviral HCV hepatitis C virus IDU injecting drug use ITT intention-to-treat NSP Needles Syringe Programs OAT opioid agonist therapy PP per-protocol PWID people who inject drugs SToP-C study the Surveillance and Treatment of Prisoners with hepatitis C study SVR sustained virological response Hepatitis C virus (HCV), a curable, bloodborne virus that causes inflammation of the liver and progressive liver damage, is more prevalent in prisons where unsafe drug injecting...

Nov 7, 2023 | onlinelibrary.wiley.com | Marianne Byrne |Behzad Hajarizadeh |Joanne Carson |Jason Grebely

1 INTRODUCTION Injecting drug use is the primary mode of hepatitis C virus (HCV) transmission across the world, particularly in high-income countries.1, 2 People who inject drugs are over-represented in prisons in most countries, primarily for drug-related offences,3 with an estimated 58% of people who inject drugs having an incarceration history globally.4 People in prison are at increased risk of HCV infection given high prevalence of injecting drug use and limited access to harm reduction...